Active Protocol

List of Active ICON Protocols

1. A Phase II study of Gemcitabine as 4 hour infusion with carboplatin in inoperable stage III and IV NSCLC (Protocol No: ICON/ LUNG/ 0105)Status:
2. Comprehensive Management for patients with Chronic Myeloid Leukemia (Protocol TMC/CML/MO-0401; Version Date 20 April 2004) – a phase II feasibility and tolerability study.Status: Ongoing
3. Combination Chemotherapy for MM (Protocol No: ICON/Hematol-MM/0306)Status: Ongoing
4. A phase II b RCT of Neo adjuvant chemotherapy comparing Paclitaxel, Ifosfamide and Cisplatin with Paclitaxel, Cisplatin and 5-FU in patients with locally advanced head & neck cancer. (Protocol No: ICON/H&N/0601)Status: Completed
5. An open label, multicentre phase I/II dose escalating study of Pablocan (NPB001-05) in patients of chronic myeloid leukemia who have demonstrated resistance / intolerance to the local prevailing standard of care.(Protocol No: ICON/CML/0701)Status: Ongoing
6. An Observational Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients with Platinum Sensitive Epithelial Relapsed Ovarian Cancer. (Protocol No: ICON/Ovary/0703)Status: Ongoing
7. A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (Omacetaxine) (CGX-635) in the Treatment of Patients with Chronic Myeloid Leukemia (CML) Who have Failed or Are Intolerant to Tyrosine Kinase Inhibitor Therapy (Protocol No. CGX-635-CML-203)Status: Ongoing
8. A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (Omacetaxine) (CGX-635) in the Treatment of Patients with Chronic Myeloid Leukemia (CML) with the T315I BCR-ABL Gene Mutation (Protocol No. CGX-635-CML-202)Status: Completed
9. Neo-Adjuvant Docetaxel + Platinum for Locally Advanced Breast Cancer: A single arm observational study (ICON/LABC/0108)Status: Discontinued.